Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ.
O'Donnell RT, et al. Among authors: lara pn.
Clin Cancer Res. 2001 Jun;7(6):1561-8.
Clin Cancer Res. 2001.
PMID: 11410491
Clinical Trial.